New Results

SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species

Sangeetha Srinivasan, Nathan A. Yee, Michael Zakharian, Maša Alečković, Amir Mahmoodi, Tri-Hung Nguyen, José M. Mejía Oneto
doi: https://doi.org/10.1101/2023.03.28.534654

Article Information

doi 
https://doi.org/10.1101/2023.03.28.534654
History 
  • March 29, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Sangeetha Srinivasan1,
  2. Nathan A. Yee1,
  3. Michael Zakharian1,
  4. Maša Alečković1,
  5. Amir Mahmoodi1,
  6. Tri-Hung Nguyen1 and
  7. José M. Mejía Oneto1,*
  1. 1Shasqi Inc, 665 3rd St, Suite 501, San Francisco, CA 94107, USA
  1. ↵*Corresponding Author
    CJosé M. Mejía Oneto, MD, PhD; Shasqi Inc., 665 3rd St, Suite 501, San Francisco, CA 94107, USA. Email: jose{at}shasqi.com
Back to top
Posted March 29, 2023.
Download PDF

Supplementary Material

Email
SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species
Sangeetha Srinivasan, Nathan A. Yee, Michael Zakharian, Maša Alečković, Amir Mahmoodi, Tri-Hung Nguyen, José M. Mejía Oneto
bioRxiv 2023.03.28.534654; doi: https://doi.org/10.1101/2023.03.28.534654
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area